Virulence-attenuated Salmonella engineered to secrete immunomodulators reduce tumour growth and increase survival in an autochthonous mouse model of breast cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Virulence-attenuated Salmonella engineered to secrete immunomodulators reduce tumour growth and increase survival in an autochthonous mouse model of breast cancer
Authors
Keywords
-
Journal
JOURNAL OF DRUG TARGETING
Volume -, Issue -, Pages 1-9
Publisher
Informa UK Limited
Online
2020-11-13
DOI
10.1080/1061186x.2020.1850739
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A review of cancer immunotherapy toxicity
- (2020) Lucy Boyce Kennedy et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Bioengineered smart bacterial carriers for combinational targeted therapy of solid tumors
- (2020) Siamak Alizadeh et al. JOURNAL OF DRUG TARGETING
- Preclinical murine tumor models: a structural and functional perspective
- (2020) Marion V Guerin et al. eLife
- Cannabinoids as anticancer therapeutic agents
- (2020) Olga Kovalchuk et al. CELL CYCLE
- IL-15 in the Combination Immunotherapy of Cancer
- (2020) Thomas A. Waldmann et al. Frontiers in Immunology
- New Technologies in Developing Recombinant Attenuated Bacteria for Cancer Therapy
- (2020) Kang Liang et al. BIOTECHNOLOGY AND BIOENGINEERING
- Microbes as Medicines: Harnessing the Power of Bacteria in Advancing Cancer Treatment
- (2020) Shruti S. Sawant et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bacteria and bacterial derivatives as drug carriers for cancer therapy
- (2020) Zhenping Cao et al. JOURNAL OF CONTROLLED RELEASE
- Salmonella enterica Typhimurium engineered for nontoxic systemic colonization of autochthonous tumors
- (2020) Lance B. Augustin et al. JOURNAL OF DRUG TARGETING
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
- (2019) Filipe Martins et al. Nature Reviews Clinical Oncology
- Critical Care Management of Toxicities Associated With Targeted Agents and Immunotherapies for Cancer
- (2019) Cristina Gutierrez et al. CRITICAL CARE MEDICINE
- Modulation of the immune microenvironment by tumor-intrinsic oncogenic signaling
- (2019) Kim Bich Nguyen et al. JOURNAL OF CELL BIOLOGY
- Antioxidative and Anti-Inflammatory Properties of Cannabidiol
- (2019) Sinemyiz Atalay et al. Antioxidants
- Low dose chemotherapy combined with attenuated Salmonella decreases tumor burden and is less toxic than high dose chemotherapy in an autochthonous murine model of breast cancer
- (2018) Daniel Saltzman et al. SURGERY
- Immuno-Oncology: Emerging Targets and Combination Therapies
- (2018) Henry T. Marshall et al. Frontiers in Oncology
- A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
- (2018) Sophie A. Millar et al. Frontiers in Pharmacology
- Tumor resistance to vascular disrupting agents: mechanisms, imaging, and solutions
- (2016) Wenjie Liang et al. Oncotarget
- Phase I Study of CKD-516, a Novel Vascular Disrupting Agent, in Patients with Advanced Solid Tumors
- (2016) Do-Youn Oh et al. Cancer Research and Treatment
- IL-15 Superagonist–Mediated Immunotoxicity: Role of NK Cells and IFN-γ
- (2015) Yin Guo et al. JOURNAL OF IMMUNOLOGY
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficiency of Conditionally Attenuated Salmonella enterica Serovar Typhimurium in Bacterium-Mediated Tumor Therapy
- (2015) Michael Frahm et al. mBio
- Vasculature Disruption Enhances Bacterial Targeting of Autochthonous Tumors
- (2015) Jeremy J. Drees et al. Journal of Cancer
- Soluble production of a biologically active single-chain antibody against murine PD-L1 in Escherichia coli
- (2013) Jeremy J. Drees et al. PROTEIN EXPRESSION AND PURIFICATION
- A global pharmaceutical company initiative: An evidence-based approach to define the upper limit of body weight loss in short term toxicity studies
- (2013) Kathryn Chapman et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Cannabidiol inhibits angiogenesis by multiple mechanisms
- (2012) M Solinas et al. BRITISH JOURNAL OF PHARMACOLOGY
- The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents
- (2010) Dietmar W. Siemann CANCER TREATMENT REVIEWS
- Identification of CKD-516: A Potent Tubulin Polymerization Inhibitor with Marked Antitumor Activity against Murine and Human Solid Tumors
- (2010) Jaekwang Lee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors
- (2009) R M Ryan et al. GENE THERAPY
- Anthrax Protective Antigen Delivered by Salmonella enterica Serovar Typhi Ty21a Protects Mice from a Lethal Anthrax Spore Challenge
- (2009) M. Osorio et al. INFECTION AND IMMUNITY
- Tumor Invasion of Salmonella enterica Serovar Typhimurium Is Accompanied by Strong Hemorrhage Promoted by TNF-α
- (2009) Sara Leschner et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation